Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 4 Oct - RBL Bank Limited informs the exchange about ESOP allotment.
Source: Bse
Financial Services stocks · Small cap · NSE
RBL Bank is an Indian private sector bank. Emirates NBD Bank (P.J.S.C) recently infused ~USD 2.75 billion, acquiring 60% of the expanded share capital and becoming its promoter. The bank offers a range of retail and wholesale banking products and services.
SMA20 +1.2% / mo · MACD −
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +54.0% · PAT +159.6% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +54% YoY · PAT +160% YoY · +41% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹5,401.7 Cr | +54.0% | +40.7% |
| EBITDA | NDF | NDF | NDF |
| Operating margin | NDF | NDF | NDF |
| PAT | ₹498.4 Cr | +159.6% | +113.0% |
| PAT margin | 9.2% | +376 bps | +314 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term uptrend intact. RSI 38. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 26 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Banks are balance-sheet businesses, so book value quality matters more than simple earnings multiples.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Financial Services — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
RBL Bank reported strong Q1 FY27 Net Profit growth of 27% YoY, driven by 31% YoY operating profit growth and 23% YoY advances growth. Capital adequacy significantly improved post ENBD's ~INR 260 billion capital infusion, while asset quality remained stable.
The substantial capital infusion by Emirates NBD has dramatically strengthened RBL Bank's capital position and led to rating upgrades, providing a strong foundation for future growth. While NII and NIM saw a slight QoQ dip, and deposits declined sequentially, overall asset quality improved, and advances growth remained robust YoY. The strategic partnership with ENBD offers significant long-term synergy potential.
Latest issuer-disclosed distribution across 2 reported categories.
Wholesale advances grew by 38% YoY to Rs.520.27 bn in Q1 FY27.
Retail Disbursals for Q1 FY27 were Rs. 74.81 bn, marking a 45% YoY growth.
Core Fee Income for Q1 FY27 grew 16% YoY to Rs.9.23 bn.
Emirates NBD Bank (P.J.S.C) infused ~USD 2.75 billion, acquiring 60% stake and becoming a promoter, providing a scalable platform in India with cross-border synergies.
Issuer Rating upgraded to ICRA AAA (Stable) and CARE AAA (Stable) for various instruments post capital infusion.
Capital adequacy ratio & CET-1 significantly increased to 33.3% & 32.2% respectively, post capital infusion.
Net Interest Margin (NIM) declined to 4.13% in Q1 FY27 from 4.41% QoQ and 4.50% YoY.
Deposits declined 10% QoQ to Rs. 1,248.29 bn.
Average CASA ratio declined to 25.2% in Q1 FY27 from 27.0% QoQ and 28.0% YoY.
Deposits declined 10% QoQ, indicating a challenge in sequential deposit accretion and CASA ratio improvement.
NIM compression observed QoQ and YoY, suggesting potential pressure on profitability if not managed effectively.
Net Slippages increased QoQ to 7.90 bn from 6.24 bn, warranting close monitoring of asset quality trends in retail segments.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
YoY comparison is crucial for assessing underlying business growth and asset quality trends, especially for a financial institution. QoQ comparison is also important to track sequential momentum in key metrics like NIM, deposit accretion, and slippages, particularly after a major capital event.
Advances grew by 23% YoY to Rs.1,162.23 bn. Wholesale advances grew 38% YoY, and Retail advances grew 13% YoY.
Retail Disbursals for Q1 FY27 were Rs. 74.81 bn, growing 45% YoY.
NIM was 4.13% for Q1 FY27, down from 4.41% QoQ and 4.50% YoY.
Cost of Funds was 6.01% for Q1 FY27, up from 5.87% QoQ but down from 6.55% YoY.
The amalgamation of three ENBD branches operating in India into RBL Bank is awaiting final approvals from authorities.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Net Interest Margin (NIM) | 4.13% | Stabilization or improvement in NIM, given the sequential decline. |
| Deposit Growth | 11% YoY, -10% QoQ | Reversal of sequential deposit decline and improvement in CASA ratio. |
| Retail Advances Share | 55% of total advances | Trend in retail advances growth and its share in the overall portfolio, especially unsecured segments. |
| Return on Equity (RoE) (excluding capital infusion impact) | ~5% (excluding capital infusion) | Improvement in reported RoE as new capital is deployed efficiently. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
The bank will be building up its Provision Coverage Ratio (PCR) to a comfortable range of 75% to 78% in the coming quarter.
"Maybe in the quarter to come, we will be building up to that extent."
The bank expects margins to be marginally better in the next quarter (Q4 FY '26) due to further repricing of term deposits and improved disbursals in better yielding assets.
"we expect the margins to be marginally better in next quarter"
The bank will sustain its branch expansion momentum to strengthen its physical footprint and support growth in retail deposits.
"we will sustain this momentum to strengthen our physical footprint and support growth in retail deposits"
Credit card slippages are expected to continue to be slightly elevated for 2 more quarters.
"we expect this trend to continue for 2 quarters -- 2 more quarters"
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 66th percentile of the scored universe and 78th percentile within Financial Services. Main check: financial discipline is weak at 28/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Financial Services: 78th pctile, median 62 · Small: 69th pctile, median 66
114 documents have extracted text, but claim history is not strong enough yet.
4 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse